Immunology
-
Rapidly Increasing Severe Acute Respiratory Syndrome Coronavirus 2 Neutralization by Intravenous Immunoglobulins Produced From Plasma Collected During the 2020 Pandemic
This article has 5 authors:Reviewed by ScreenIT
-
Potent Neutralization of SARS-CoV-2 by Hetero-Bivalent Alpaca Nanobodies Targeting the Spike Receptor-Binding Domain
This article has 15 authors:Reviewed by ScreenIT
-
A prefusion SARS-CoV-2 spike RNA vaccine is highly immunogenic and prevents lung infection in non-human primates
This article has 61 authors:Reviewed by ScreenIT
-
Delayed induction of type I and III interferons mediates nasal epithelial cell permissiveness to SARS-CoV-2
This article has 28 authors:Reviewed by ScreenIT
-
T-cell Repertoire Characteristics of Asymptomatic and Re-detectable Positive COVID-19 Patients
This article has 16 authors:Reviewed by ScreenIT
-
An effective, safe and cost-effective cell-based chimeric vaccine against SARS-CoV2
This article has 19 authors:Reviewed by ScreenIT
-
Potent Neutralization Antibodies Induced by a Recombinant Trimeric Spike Protein Vaccine Candidate Containing PIKA Adjuvant for COVID-19
This article has 5 authors:Reviewed by ScreenIT
-
SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls
This article has 19 authors:Reviewed by ScreenIT
-
Driving potent neutralization of a SARS-CoV-2 Variant of Concern with a heterotypic boost
This article has 13 authors:Reviewed by ScreenIT
-
Induction of SARS-CoV-2 Protein S-Specific CD8+ T Cells in the Lungs of gp96-Ig-S Vaccinated Mice
This article has 8 authors:Reviewed by ScreenIT